E-prescriptions, triptans and COVID-19 vaccines: your questions answered
In this monthly series, Australian Pharmacist speaks to the experts to answer some of your most frequently asked questions.
How pharmacy fared in this year’s Budget
The new federal government last night delivered its 2022–23 ‘bread and butter’ Budget amid a growing cost-of-living crisis.
Chronic pain – the role of pharmacists
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
Glauber’s salt: the laxative of choice until the 1900s
Until ‘more sophisticated alternatives’ came about in the 1900s, Glauber’s salt was the global go-to purgative.
Expect an increase in demand for long-acting injectable buprenorphine
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
Changes to PBS antibiotic prescribing
In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...
